CEO Update - 28 May 2024

UK General Election

The UK General Election has been called for Thursday 4 July. In practical terms, this means the end of the legislative pathway for many proposals as Parliament shuts down. It also means the policy-making function of the civil service machine slows to a crawl and with it the cancellation of planned formal meetings of government and industry, like the Life Science Council in June.

The parliamentary careers of over 100 MPs are also coming to an end as many have chosen to step down at this election – like Tunbridge Wells MP Greg Clark, the current Chair of the Science, Innovation and Technology Select Committee.

As there will be no Parliament in June, we’ve had to postpone our Parliament Day this year. We plan to rearrange it for the Autumn when a fresh government and hundreds of new MPs will no doubt be keen to engage with our members.

Newscast becomes General Election update

Over the next six weeks, we will use Newscast to update on notable moments from the campaigns that impact our sector.

We will summarise what we've learned in a webinar on 25 June (1-2pm), one week before polling day. The webinar will consider what various election outcomes could mean for the sector and its stakeholders. Join us to get the latest and to ask questions of the BIA team, and watch out for the post-election readout the week after for an analysis of the results and implications.

Webinar on new government

We will also look to provide timely insight into who is who in the new government and what this means for our sector. A new government brings new Ministers, new policies and potentially new structures within the civil service, all of which could have profound consequences for the life sciences sector and its stakeholders. If you're not familiar with the basic contours of a UK General Election campaign, this is a useful explainer.

We will host this second webinar between the General Election and the forthcoming King's Speech early in July. Look out for the date and time being announced shortly. 

Do you want to host a campaign visit?

Although life science policy is unlikely to be central to the election campaign, we are offering to connect BIA member companies who are keen to host a campaign visit with the political parties of their choice. The main parties have procedures for, and dedicated folk whose task is to both arrange visits and seek endorsements from business. I am happy to make introductions for members who wish to navigate these channels. And, of course, it would be nice to see life science businesses demonstrating both the economic and health value their presence brings to our nation during this campaign. This guide on what works is useful

If you would like to host, please email [email protected]; for those of you who are not yet BIA members, please feel free to get in touch with George and Ekin to learn more about the benefits of joining.

Better regulation documents published

Although it is hard to ascertain what from this government will be picked up by the next, I did note the publication of two documents late last week about Smarter Regulation and the future of regulation published by the Department of Business and Trade. The details about engineering biology sandboxes are apposite for our community.

WIPO treaty agreed

After decades of negotiation, on 24 May, member states of the World Intellectual Property Office (WIPO) approved a new treaty relating to IP, genetic resources and associated traditional knowledge. In essence, the treaty will establish in international law a new disclosure requirement for patent applicants whose inventions are based on genetic resources and/or associated traditional knowledge. BIA have been in close conversation with the UK IPO throughout the negotiations leading up to the WIPO diplomatic conference, in order to ensure the treaty articles do not lead to burdensome requirements of proof for innovators, and that any sanctions are proportionate, among other. The treaty is not yet ratified and will need 15 contracting parties to enter into force. BIA will engage closely as conversations will continue between WIPO member states, including the UK.

BIO 2024 less than a week away

The BIO International Convention is a little under a week away. It is being held in San Diego this year. The BIA will be present at the UK Pavilion located in Hall B, booth 2025. Because there's a General Election there will be no minister at the convention this year.

We are looking forward to hosting the key reception for UK delegates on Tuesday 4 June (19:00-21:00 PT) at Hilton San Diego Bayfront. There is also the UK’s on-stand reception (17:00-18:30 PT).

Other ways to get involved:

  • Attend the BIO Super Session: Spurring Biotech Innovation Across the Globe: A High-Level Discussion on Tuesday 4 June (10:45-12:00 PT) 
  • Attend the Global Innovation Hub seminar: The UK: Inspired, Innovative and International on Tuesday 4 June (12:15-12:30 PT)
  • Visit the UK@BIO microsite to learn more about the UK Pavilion exhibitors and partners.
  • Connect with BIA representatives - Associate Directors Alina O’Keeffe and Martin Turner - get in touch with them ahead of or during the conference!

We look forward to celebrating the global reach and impact of the UK’s life science sector with senior UK government officials and policymakers, and key industry and academic leaders from the UK, US and beyond.

Steve Bates Headshot.png

 

 

Steve Bates OBE
CEO, BioIndustry Association

 

More news and updates 

Promising results from cardiac fibrosis studies with MRX1

Ananda Developments PLC, a clinical-stage life sciences company focused on the development of CBD based therapies for the treatment of a range of complex inflammatory pain conditions, is delighted to share promising results from recent preclinical studies investigating the efficacy of MRX1 (Patent Pending) in treating cardiac fibrosis and heart failure with preserved ejection fraction (HFpEF).

Valneva Scotland appoints science communications consultancy, Perceptive Communicators

Glasgow-based specialist communications consultancy, Perceptive Communicators, has announced its appointment to provide strategic communications services for Valneva Scotland.

CEO Update - 1 July 2024

I will watch the General Election this Thursday with great interest, like the rest of the country, and update you on the new ministers and members of Parliament next week. You can access the policy backgrounds of the main parties and view our webinar on what the campaign has taught us about what our sector should expect from the new parliament and government.

Shaping future leaders in biomanufacturing: insights from MAC LeaP

Over the past nine years, Dr Tony Bradshaw, Managing Director of Biosocius, has collected data from three distinct projects within the biotechnology sector. This effort has yielded unique and valuable insights that can help professionals thrive and build sustainable, fulfilling careers. By analysing behavioural profiles and consulting with industry experts, we can better understand the evolving demands of leadership in bioscience.

Coulter Partners places Head of Sales North America at Pelago Bioscience

Coulter Partners recently partnered with Pelago Bioscience and is pleased to announce the placement of Brian Jarecki, PhD as Head of Sales North America.

Discovery Park Innovation Summit showcases Kent’s ambition to be a leader in healthy ageing

Discovery Park welcomed experts in healthy ageing to its Innovation Summit on 20th June, calling for the life science network in Kent to join forces to make the county a leader in healthy ageing and longevity.

Cryoport Systems officially launches global supply chain hub in Stevenage, U.K.

Cryoport Systems' new global Supply chain hub in Stevenage will enhance the company's ability to provide comprehensive supply chain and logistics solutions for advanced therapy manufacturers in the UK and across Europe.

Why digital matters for neurodegeneration treatments

Molly Andrews of the UK Dementia Research Institute, Priya Kalia of SciTribe, and Miranda Weston-Smith of BioBeat highlight the urgent need for innovative digital solutions and investments in the accurate diagnosis and effective treatment of neurodegenerative diseases, as emphasised at BioBeat24.

Engitix appoints two additional international biotech industry leaders as Scientific Advisors

Engitix Ltd announced the appointment of two biotech industry leaders as Scientific Advisors: Adrian S. Ray, PhD, and Scott Turner, PhD.

RoslinCT appoints Professor Sir Peter Mathieson and Alexander Vos as Non-Executive Directors

RoslinCT is pleased to announce the appointment of Professor Sir Peter Mathieson MB BS (Hons), PhD, FRCP, FRCPE, FMedSci, FRSE, FRSA and Alexander Vos as new Non-Executive Directors.

CEO Update - 24 June 2024

In two Newscasts time, we will know the outcome of the UK General Election to be held on Thursday, 4 July. Join our webinar tomorrow at 1 pm where we will discuss what we have learned from the campaigns and manifestoes about potential future policies and people important for our sector after the result.

Rare Disease Community Event – meeting report

On 6 June 2024, the MRC National Mouse Genetics Network (NMGN) and the Mary Lyon Centre at MRC Harwell (MLC) hosted a Resources and Funding Opportunities in Rare Diseases event at the Advance Training Centre aimed at sharing information on resources and funding opportunities in the specific area of preclinical and clinical research and fostering new collaborative initiatives between academia, industry and advocacy/patient groups.

More within